```html

Yellowing of Skin or Eyes (Jaundice)

What is Yellowing of skin or eyes (Jaundice)?

Jaundice is a visible yellow discoloration of the skin, sclera (the white part of the eyes), and sometimes mucous membranes. The hue results from an excess of bilirubin—a yellow‑orange pigment produced when red blood cells break down. Normally, the liver processes bilirubin and releases it into the intestines for elimination. When production exceeds the liver’s ability to clear it, or when the pathways for elimination are blocked, bilirubin builds up in the bloodstream and deposits in tissues, producing the characteristic yellow tint.

Jaundice itself is not a disease; it is a sign that something is affecting the normal metabolism of bilirubin. Identifying the underlying cause is essential because the range of possible conditions varies from harmless, temporary issues to life‑threatening liver failure.

Sources: Mayo Clinic, CDC, NIH

Common Causes

The following conditions are among the most frequent reasons for jaundice. They can be grouped into three broad categories: pre‑hepatic (before the liver), hepatic (within the liver), and post‑hepatic (after the liver).

• Hemolytic anemia – accelerated destruction of red blood cells releases large amounts of bilirubin (pre‑hepatic).
• Viral hepatitis (A, B, C, D, E) – inflammation damages liver cells, impairing bilirubin processing (hepatic).
• Alcoholic liver disease – chronic alcohol use leads to fatty change, hepatitis, and cirrhosis (hepatic).
• Non‑alcoholic fatty liver disease (NAFLD) / non‑alcoholic steatohepatitis (NASH) – excess fat in the liver impairs function (hepatic).
• Biliary obstruction – gallstones, strictures, or tumors block bile flow, causing bilirubin to back‑up (post‑hepatic).
• Primary biliary cholangitis (PBC) & primary sclerosing cholangitis (PSC) – autoimmune attacks on bile ducts (post‑hepatic).
• Medication‑induced liver injury – acetaminophen overdose, certain antibiotics, antiepileptics, and statins can damage hepatocytes (hepatic).
• Gilbert’s syndrome – a benign genetic reduction in the enzyme that conjugates bilirubin; often reveals itself during illness or fasting (hepatic).
• Pancreatic cancer – tumor in the head of the pancreas can compress the common bile duct (post‑hepatic).
• Neonatal jaundice – newborns have immature liver enzymes; typically resolves within weeks but can be severe in premature infants.

Other less common causes include hemoglobinopathies (e.g., sickle cell disease), sepsis, and hereditary defects such as Crigler‑Najjar syndrome.

Associated Symptoms

Jaundice rarely occurs in isolation. The accompanying signs often help narrow down the cause.

• Dark urine (bilirubin excreted by kidneys)
• Pale or clay‑colored stools (lack of bile pigments)
• Itchy skin (pruritus) – especially with cholestatic (bile flow) disorders
• Abdominal pain or fullness, particularly in the right upper quadrant
• Fatigue, weakness, or loss of appetite
• Fever and chills – suggest infection such as cholangitis
• Weight loss (unexplained) – may indicate malignancy
• Swelling of the abdomen (ascites) or legs (edema) – signs of advanced liver disease
• Confusion, difficulty concentrating, or “metallic” taste – a sign of hepatic encephalopathy

When to See a Doctor

Because jaundice can herald serious disease, prompt medical evaluation is advised, especially if any of the following occur:

• Yellowing that spreads rapidly over a few days
• Accompanying severe abdominal pain, especially in the upper right side
• Fever >100.4°F (38°C) or chills
• Dark urine, pale stools, or persistent itching
• Confusion, drowsiness, or difficulty staying awake
• Vomiting, especially with coffee‑ground appearance (GI bleeding)
• Recent use of new medications, herbal supplements, or over‑the‑counter acetaminophen at high doses
• History of liver disease, hepatitis, heavy alcohol use, or family history of genetic bilirubin disorders

If you are a newborn and notice yellowing of the skin or eyes, contact your pediatrician immediately; neonatal jaundice can progress to brain injury if untreated.

Diagnosis

Evaluation begins with a thorough history and physical exam, followed by targeted laboratory and imaging studies.

Laboratory Tests

• Serum bilirubin levels – total, direct (conjugated) and indirect (unconjugated). A higher direct fraction points to hepatic or post‑hepatic causes, whereas a predominant indirect fraction suggests pre‑hepatic or hereditary conditions.
• Liver function panel – ALT, AST, alkaline phosphatase (ALP), gamma‑glutamyl transferase (GGT), and albumin. Elevated ALT/AST imply hepatocellular injury; high ALP/GGT suggest cholestasis.
• Complete blood count (CBC) – to detect hemolysis (low hemoglobin, high reticulocyte count) or infection.
• Coagulation profile (PT/INR) – assesses synthetic function of the liver.
• Viral hepatitis serologies – Hepatitis A IgM, Hepatitis B surface antigen & core antibody, Hepatitis C antibody.
• Autoimmune markers – ANA, anti‑smooth muscle, antimitochondrial antibodies (AMA) when autoimmune hepatitis or PBC is suspected.
• Hemolysis work‑up – haptoglobin, lactate dehydrogenase (LDH), peripheral smear.

Imaging Studies

• Abdominal ultrasound – first‑line to evaluate gallstones, biliary duct dilatation, liver texture, and masses.
• CT or MRI – for detailed assessment of pancreatic tumors, malignant obstruction, or liver lesions.
• Endoscopic retrograde cholangiopancreatography (ERCP) – therapeutic and diagnostic for biliary obstruction.
• Magnetic resonance cholangiopancreatography (MRCP) – non‑invasive visualization of the biliary tree.

Additional Tests

• **Liver biopsy** – rarely needed, but can clarify ambiguous cases (e.g., autoimmune hepatitis, NASH).
• **Genetic testing** – for rare inherited disorders such as Gilbert’s or Crigler‑Najjar syndrome.

Treatment Options

Treatment targets the underlying cause; the jaundice itself usually resolves once bilirubin metabolism normalizes.

Medical Therapies

• Antiviral therapy for chronic hepatitis B (e.g., entecavir, tenofovir) or C (direct‑acting antivirals).
• Corticosteroids or immunosuppressants for autoimmune hepatitis.
• Ursodeoxycholic acid (UDCA) for primary biliary cholangitis and gallstone dissolution.
• Antibiotics for cholangitis (e.g., ceftriaxone) and sepsis.
• Chemotherapy, radiation, or targeted therapy for malignant causes (pancreatic or cholangiocarcinoma).
• Phototherapy for severe neonatal jaundice – blue light converts bilirubin into water‑soluble forms.
• Liver transplant in end‑stage cirrhosis or acute liver failure when other treatments fail.

Supportive & Home Care Measures

• Maintain adequate hydration – helps the kidneys excrete bilirubin.
• Eat a balanced diet rich in fruits, vegetables, and lean protein; limit saturated fats and processed sugars.
• Avoid alcohol and hepatotoxic medications (e.g., excessive acetaminophen).
• For pruritus, cool oatmeal baths, antihistamines, or prescribed cholestyramine can relieve itching.
• If gallstones are present, weight management and a low‑fat diet may reduce future stone formation.

Prevention Tips

While some causes (genetic) cannot be prevented, many risk factors are modifiable.

• Vaccinate against hepatitis A and B.
• Practice safe injection and sexual hygiene to lower hepatitis C risk.
• Limit alcohol consumption – no more than 1 drink per day for women, 2 for men.
• Maintain a healthy weight and regular exercise to prevent NAFLD/NASH.
• Use medications responsibly; follow dosing guidelines and avoid mixing alcohol with acetaminophen or other hepatotoxic drugs.
• Regular medical check‑ups if you have known liver disease, diabetes, or high cholesterol.
• For newborns, ensure early feeding and follow pediatric follow‑up to detect neonatal jaundice promptly.

Emergency Warning Signs

Summary

Jaundice—yellowing of the skin or eyes—is a visual cue that the body’s bilirubin processing system is disrupted. A wide array of conditions, from benign genetic traits to serious liver disease or biliary blockage, can cause it. Recognizing accompanying symptoms, promptly seeking care for red‑flag signs, and undergoing appropriate laboratory and imaging studies are essential steps toward an accurate diagnosis. Treatment hinges on correcting the underlying disorder, while lifestyle modifications can reduce the risk of many preventable causes. If you notice unexplained yellowing, especially with any of the emergency warning signs listed above, contact a healthcare professional without delay.

References: Mayo Clinic. “Jaundice.” 2023; CDC. “Hepatitis A, B, C Fact Sheets.” 2022; NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Liver Disease.” 2024; Cleveland Clinic. “Biliary Obstruction.” 2023; WHO. “Global hepatitis report.” 2022.

```